IL6 and myeloid sarcoma: However, this is not the only beneficial mechanism, as a reduction in IL-6 may lead to an improvement in the elimination of pathogens or nullify T-cell activation, which is known to have the ability to alleviate the course and clinical symptoms of MS [45].